NEW YORK, June 14, 2024 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against CVS Health Corporation (“CVS” or the “Company”) (NYSE: CVS) on behalf of CVS stockholders. Our investigation concerns whether CVS has violated the federal securities laws and/or engaged in other unlawful business practices.
Click here to participate in the action.
On June 10, 2024, an article was published on bloomberg.com alleging that “[o]ne factory making CVS-branded pain and fever medications for children used contaminated water. Another made drugs for kids that were too potent. And a third made nasal sprays for babies on the same machines it used to produce pesticides”. The article further describes how “[t]he drugs were among those sold by CVS Health Corp., the largest US pharmacy, under its store-brand label before being recalled,” and “over the past decade CVS’s have been recalled about two times more than those from Walgreens Boots Alliance Inc. and three times more than those from Walmart Inc”.
Following the publishing of the article, CVS’s stock price fell $1.50 per share to close at $60.28 per share on June 10, 2024.
If you purchased or otherwise acquired CVS shares and suffered a loss, are a long-term stockholder, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Marion Passmore by email at investigations@bespc.com, by telephone at (212) 355-4648, or by filling out this contact form. There is no cost or obligation to you.
About Bragar Eagel & Squire, P.C.:
Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York, California, and South Carolina. The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country. For more information about the firm, please visit www.bespc.com. Attorney advertising. Prior results do not guarantee similar outcomes.
Contact Information:
Bragar Eagel & Squire, P.C.
Brandon Walker, Esq.
Marion Passmore, Esq.
(212) 355-4648
investigations@bespc.com
www.bespc.com
- Theratechnologies enters into Definitive Agreement to be Acquired by CB Biotechnology, an Affiliate of Future Pak - July 2, 2025
- Commodities & Resources PTE Ltd. Announces Acquisition of Shares of Belmont Resources Inc. Pursuant to Private Placement - July 2, 2025
- Commodities & Resources PTE Ltd. Announces Acquisition of Shares of Belmont Resources Inc. Pursuant to a Convertible Loan Agreement - July 2, 2025
